Skip to main content

Table 3 Family medical history

From: Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry

 

Psoriasis patients self-reporting PsA, established by a HCPa (N = 1719)

Psoriasis patients self-reporting PsAb (N = 4315)

Patients with psoriasis onlyc (N = 7775)

All PSOLAR patientsd (N = 12,090)

Patients with family history data, N

1676

4205

7520

11,725

Psoriatic arthritis

275 (16.4)*

736 (17.5)*

471 (6.3)

1207 (10.3)

Cardiovascular disease

894 (53.3)*

2105 (50.1)*

3124 (41.5)

5229 (44.6)

Psoriasis

837 (49.9)*

2041 (48.5)*

3286 (43.7)

5327 (45.4)

Inflammatory bowel disease

135 (8.1)

345 (8.2)*

423 (5.6)

768 (6.6)

 Indeterminate colitis

48 (2.9)

94 (2.2)

108 (1.4)

202 (1.7)

 Crohn’s disease

40 (2.4)

75 (1.8)

125 (1.7)

200 (1.7)

 Ulcerative colitis

41 (2.4)

62 (1.5)

94 (1.3)

156 (1.3)

 Sprue/Celiac disease

7 (0.4)

12 (0.3)

30 (0.4)

42 (0.4)

Diabetes

683 (40.8)**

1755 (41.7)*

2768 (36.8)

4523 (38.6)

Other cancer

640 (38.2)*

1508 (35.9)*

2393 (31.8)

3901 (33.3)

Asthma

371 (22.1)*

918 (21.8)*

1338 (17.8)

2256 (19.2)

Thyroid disease

307 (18.3)*

771 (18.3)*

1114 (14.8)

1885 (16.1)

Non-melanoma skin cancer

203 (12.1)**

518 (12.3)*

749 (10.0)

1267 (10.8)

Rashes

152 (9.1)

304 (7.2)ns

464 (6.2)

768 (6.6)

Melanoma skin cancer

102 (6.1)**

268 (6.4)*

367 (4.9)

635 (5.4)

Multiple sclerosis

30 (1.8)

99 (2.4)*

112 (1.5)

211 (1.8)

Vitiligo

47 (2.8)**

103 (2.4)ns

128 (1.7)

231 (2.0)

None

127 (7.6)

369 (8.8)*

992 (13.2)

1361 (11.6)

  1. Values are n (%)
  2. HCP healthcare provider, PsA psoriatic arthritis, ns not significant
  3. *p < 0.001 vs. patients with psoriasis only
  4. ** p < 0.05 vs. patients with psoriasis only
  5. ns indicates non-significant for psoriasis patients self-reporting PsA vs. patients with psoriasis only
  6. P-values for categorical variables were obtained from Pearson chi-square test with patients with psoriasis only as a reference
  7. aA subset of PSOLAR psoriasis patients self-reporting PsA, established by a HCP
  8. bPSOLAR psoriasis patients with self-reported PsA
  9. cPSOLAR psoriasis patients not self-reporting PsA
  10. dIncludes all PSOLAR patients with psoriasis who may or may not have PsA